bacterin international holdi (BONE) Key Developments
Bacterin International Holdings, Inc. Appoints David Goodman as New Board Member
Aug 13 14
Bacterin International Holdings, Inc. announced the addition of David Goodman, MD, MSE to the board of directors. Dr. Goodman brings extensive experience in executive management through previous roles as CEO of SEDLine and EVP of Business Development for Masimo. The Board unanimously elected Dr. Goodman to fill the vacancy created by Mitchell Godfrey's recent resignation. Dr. Goodman currently serves as Co-Founder and CMO of FirstVitals Health & Wellness, a technology-enabled service company focused on preventing complications such as foot ulcers and lower extremity amputations in people with diabetes. He also serves on the board of NEUROMetrix and was previously on the board of Sound Surgical prior to its acquisition by Solta Medical.
Bacterin International Holdings, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014
Aug 12 14
Bacterin International Holdings, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company's total revenue was $8,883,932 against $8,266,848 a year ago. Loss from operations was $1,332,009 against $1,866,984 a year ago. Net loss was $1,900,430 or $0.35 basic and dilutive per share against $2,483,091 or $0.55 basic and dilutive per share a year ago. EBITDA was $769,645 against $1,427,054 a year ago.
For the six months, the company's total revenue was $17,796,902 against $16,885,655 a year ago. Loss from operations was $2,524,010 against $3,100,403 a year ago. Net loss was $6,040,685 or $1.11 basic and dilutive per share against $4,152,349 or $0.94 basic and dilutive per share a year ago. EBITDA was $1,484,829 against $2,491,767 a year ago.
Bacterin International Mulls Acquisitions; Files For Offering
Jul 31 14
Bacterin International Holdings, Inc. (AMEX:BONE) has filed a follow-on equity offering and make seek acquisitions. The company intends to use the net proceeds from this offering primarily for working capital and general corporate purposes. General corporate purposes may include providing working capital, funding capital expenditures, or paying for acquisitions.
Bacterin International Holdings, Inc. to Report Q2, 2014 Results on Aug 12, 2014
Jul 29 14
Bacterin International Holdings, Inc. announced that they will report Q2, 2014 results After-Market on Aug 12, 2014
Bacterin International Holdings, Inc. Files Certificate of Amendment of Restated Certificate of Incorporation
Jul 25 14
Bacterin International Holdings, Inc. filed a Certificate of Amendment of Restated Certificate of Incorporation with the Delaware Secretary of State. The Amendment provides that each ten shares of the company's common stock will be reclassified and combined into one share of common stock effective July 25, 2014. The Reverse Stock Split will be effective for trading purposes beginning July 28, 2014.